SEC Form 4 research
| Issuer | ZIOPHARM ONCOLOGY INC |
|---|---|
| Tickers | ESWB, ZIOP, TCRT |
| Reporting owners | 54 |
| Officers and directors | 18 |
| Last public filing | 2026-10-08 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-08 | 2026-10-06 | Weis Holger | A | 23,564 | $0.74 | Not reported |
| 2026-10-08 | 2026-10-06 | Vieser Jaime | A | 22,669 | $0.74 | Not reported |
| 2026-10-08 | 2026-10-06 | Postma Robert W | A | 21,829 | $0.74 | Not reported |
| 2026-10-08 | 2026-10-06 | Jerman Michael Allen | A | 20,990 | $0.74 | Not reported |
| 2026-08-11 | 2026-08-06 | Weis Holger | A | 4,363 | $2.01 | Not reported |
| 2026-07-27 | 2026-07-23 | Jerman Michael Allen | A | 8,138 | $1.92 | Not reported |
| 2026-07-27 | 2026-07-23 | Weis Holger | A | 4,568 | $1.92 | Not reported |
| 2026-07-27 | 2026-07-23 | Postma Robert W | A | 8,463 | $1.92 | Not reported |
| 2026-07-27 | 2026-07-23 | Vieser Jaime | A | 8,789 | $1.92 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.